SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zydus Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532321

INE010B01027

215.0764496

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZYDUSLIFE

20.11

94475.31

EPS(TTM)

Face Value()

Div & Yield %

46.69

1.17

Back

NTPC receives ESG rating of 74.3

Apr 10,2026

NTPC has received an Environmental, Social and Governance (ESG) rating of “74.3” [Category: Leadership] from CARE ESG Ratings. Pillar wise weights and ESG scores of the Company are as under:

Environment (45%): 62.7
Social (30%): 84.0 and
Governance (25%): 83.6

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)